// OVERVIEW
Pharma-AI convergence company combining traditional pharmaceuticals with personalized AI treatment apps
Discussed in
// RECENT MENTIONS
// SIGNALS
4 SIGNALS
01
funding·StrictlyVC·AUGUST 22, 2026
“Remepy...$36M Series A; combines prescription drugs with personalized therapeutic apps”
Source→02
03
mention·Parsers VC·AUGUST 18, 2026
“Healthcare AI and biotech formed a second major cluster. Flagler Health, HealthSnap, Remepy, Infinimmune, Amplifica, and Vedanta Biosciences show continued investor interest in automation, digital therapeutics, drug discovery, and clinical platforms.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.